PubRank

Richard J Caselli

Author PubWeight™ 102.51‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers. Neuron 2007 6.88
2 Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia. Proc Natl Acad Sci U S A 2003 6.46
3 Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease. Proc Natl Acad Sci U S A 2009 5.55
4 Novel mutations in TARDBP (TDP-43) in patients with familial amyotrophic lateral sclerosis. PLoS Genet 2008 3.66
5 Common Kibra alleles are associated with human memory performance. Science 2006 3.30
6 Correlations between apolipoprotein E epsilon4 gene dose and brain-imaging measurements of regional hypometabolism. Proc Natl Acad Sci U S A 2005 3.02
7 Alzheimer's Prevention Initiative: a plan to accelerate the evaluation of presymptomatic treatments. J Alzheimers Dis 2011 2.78
8 Common variation in the miR-659 binding-site of GRN is a major risk factor for TDP43-positive frontotemporal dementia. Hum Mol Genet 2008 2.48
9 Altered neuronal gene expression in brain regions differentially affected by Alzheimer's disease: a reference data set. Physiol Genomics 2008 2.11
10 Gene expression profiles in anatomically and functionally distinct regions of the normal aged human brain. Physiol Genomics 2006 1.88
11 Development of methodology for conducting clinical trials in frontotemporal lobar degeneration. Brain 2008 1.82
12 Posterior cingulate glucose metabolism, hippocampal glucose metabolism, and hippocampal volume in cognitively normal, late-middle-aged persons at 3 levels of genetic risk for Alzheimer disease. JAMA Neurol 2013 1.75
13 Correlations between apolipoprotein E epsilon4 gene dose and whole brain atrophy rates. Am J Psychiatry 2007 1.68
14 Current epidemiology of mild cognitive impairment and other predementia syndromes. Am J Geriatr Psychiatry 2005 1.63
15 Reduced posterior cingulate mitochondrial activity in expired young adult carriers of the APOE ε4 allele, the major late-onset Alzheimer's susceptibility gene. J Alzheimers Dis 2010 1.54
16 Variants in triggering receptor expressed on myeloid cells 2 are associated with both behavioral variant frontotemporal lobar degeneration and Alzheimer's disease. Neurobiol Aging 2013 1.53
17 Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseases. Hum Mol Genet 2012 1.46
18 Depressive symptoms in healthy apolipoprotein E ε4 carriers and noncarriers: a longitudinal study. J Clin Psychiatry 2013 1.41
19 Hippocampal adaptation to face repetition in healthy elderly and mild cognitive impairment. Neuropsychologia 2004 1.35
20 Length of normal alleles of C9ORF72 GGGGCC repeat do not influence disease phenotype. Neurobiol Aging 2012 1.30
21 Blood pressure is associated with higher brain amyloid burden and lower glucose metabolism in healthy late middle-age persons. Neurobiol Aging 2011 1.27
22 Regional network of magnetic resonance imaging gray matter volume in healthy aging. Neuroreport 2006 1.27
23 Identification of a novel risk locus for progressive supranuclear palsy by a pooled genomewide scan of 500,288 single-nucleotide polymorphisms. Am J Hum Genet 2007 1.24
24 Evidence for an association between KIBRA and late-onset Alzheimer's disease. Neurobiol Aging 2008 1.24
25 Cognitive performance in older women relative to ApoE-epsilon4 genotype and aerobic fitness. Med Sci Sports Exerc 2007 1.22
26 Linking functional and structural brain images with multivariate network analyses: a novel application of the partial least square method. Neuroimage 2009 1.17
27 Higher serum total cholesterol levels in late middle age are associated with glucose hypometabolism in brain regions affected by Alzheimer's disease and normal aging. Neuroimage 2009 1.17
28 Apolipoprotein E epsilon 4 affects new learning in cognitively normal individuals at risk for Alzheimer's disease. Neurobiol Aging 2003 1.10
29 Quantitation of heteroplasmy of mtDNA sequence variants identified in a population of AD patients and controls by array-based resequencing. Mitochondrion 2006 1.07
30 Ushering in the study and treatment of preclinical Alzheimer disease. Nat Rev Neurol 2013 1.03
31 Small-amplitude cortical myoclonus in Parkinson's disease: physiology and clinical observations. Mov Disord 2002 1.02
32 Hypometabolism in Alzheimer-affected brain regions in cognitively healthy Latino individuals carrying the apolipoprotein E epsilon4 allele. Arch Neurol 2010 1.02
33 Off-label medication use in frontotemporal dementia. Am J Alzheimers Dis Other Demen 2010 1.01
34 Increased tau burden in the cortices of progressive supranuclear palsy presenting with corticobasal syndrome. Mov Disord 2005 1.01
35 Neuronal gene expression in non-demented individuals with intermediate Alzheimer's Disease neuropathology. Neurobiol Aging 2008 1.00
36 Gray matter network associated with risk for Alzheimer's disease in young to middle-aged adults. Neurobiol Aging 2012 1.00
37 Cognitive frailty: Predementia syndrome and vascular risk factors. Neurobiol Aging 2005 0.99
38 Novel mutation in MAPT exon 13 (p.N410H) causes corticobasal degeneration. Acta Neuropathol 2014 0.98
39 Higher serum glucose levels are associated with cerebral hypometabolism in Alzheimer regions. Neurology 2013 0.98
40 Cognitive impairment, frontotemporal dementia, and the motor neuron diseases. Ann Neurol 2003 0.98
41 Depressive symptoms, vascular risk factors and mild cognitive impairment. The Italian longitudinal study on aging. Dement Geriatr Cogn Disord 2008 0.96
42 Autoimmune encephalopathy. Semin Neurol 2011 0.96
43 Temporal relationship between depressive symptoms and cognitive impairment: the Italian Longitudinal Study on Aging. J Alzheimers Dis 2009 0.96
44 Cholesterol-related genetic risk scores are associated with hypometabolism in Alzheimer's-affected brain regions. Neuroimage 2008 0.96
45 Genetic influence of apolipoprotein E4 genotype on hippocampal morphometry: An N = 725 surface-based Alzheimer's disease neuroimaging initiative study. Hum Brain Mapp 2014 0.96
46 A roadmap for improving healthcare service quality. J Healthc Manag 2011 0.91
47 Disrupted daytime activity and altered sleep-wake patterns may predict transition to mild cognitive impairment or dementia: a critically appraised topic. Neurologist 2012 0.90
48 Incident occurrence of depressive symptoms among patients with mild cognitive impairment - the Italian longitudinal study on aging. Dement Geriatr Cogn Disord 2007 0.89
49 APOE and neuroenergetics: an emerging paradigm in Alzheimer's disease. Neurobiol Aging 2012 0.88
50 Longitudinal tracking of FTLD: toward developing clinical trial methodology. Alzheimer Dis Assoc Disord 2007 0.88
51 Assessment of patient and caregiver experiences of dementia-related symptoms: development of the Multidimensional Assessment of Neurodegenerative Symptoms questionnaire. Dement Geriatr Cogn Disord 2009 0.86
52 Association between GAB2 haplotype and higher glucose metabolism in Alzheimer's disease-affected brain regions in cognitively normal APOEε4 carriers. Neuroimage 2010 0.86
53 Nonvasculitic autoimmune inflammatory meningoencephalitis as a cause of potentially reversible dementia: report of 4 cases. J Neurosurg 2008 0.86
54 "Idiopathic" rapid-eye-movement (REM) sleep behavior disorder is associated with future development of neurodegenerative diseases. Neurologist 2007 0.86
55 Double-blind crossover study of the cognitive effects of lorazepam in healthy apolipoprotein E (APOE)-epsilon4 carriers. J Clin Psychiatry 2009 0.85
56 Appraisal of cognition in preclinical Alzheimer's disease: a conceptual review. Neurodegener Dis Manag 2012 0.85
57 Correlations between FDG PET glucose uptake-MRI gray matter volume scores and apolipoprotein E ε4 gene dose in cognitively normal adults: a cross-validation study using voxel-based multi-modal partial least squares. Neuroimage 2012 0.85
58 Adjunctive haloperidol prophylaxis reduces postoperative delirium severity and duration in at-risk elderly patients. Neurologist 2008 0.84
59 Association between an Alzheimer's Disease-Related Index and APOE ε4 Gene Dose. PLoS One 2013 0.84
60 Statins differentially affect amyloid precursor protein metabolism in presymptomatic PS1 and non-PS1 subjects. Arch Neurol 2007 0.83
61 Anxiety affects cognition differently in healthy apolipoprotein E ε4 homozygotes and non-carriers. J Neuropsychiatry Clin Neurosci 2011 0.83
62 Patterns of brain atrophy in clinical variants of frontotemporal lobar degeneration. Dement Geriatr Cogn Disord 2013 0.81
63 Whole genome association analysis shows that ACE is a risk factor for Alzheimer's disease and fails to replicate most candidates from Meta-analysis. Int J Mol Epidemiol Genet 2009 0.81
64 Efficacy of rivastigmine for cognitive symptoms in Parkinson disease with dementia. Neurologist 2009 0.78
65 Childhood-onset multiple sclerosis with progressive dementia and pathological cortical demyelination. Arch Neurol 2011 0.78
66 Physical activity level and future risk of mild cognitive impairment or dementia: a critically appraised topic. Neurologist 2015 0.78
67 Effectiveness of adding memantine to an Alzheimer dementia treatment regimen which already includes stable donepezil therapy: a critically appraised topic. Neurologist 2011 0.77
68 Autoimmune encephalopathy. Mayo Clin Proc 2010 0.77
69 Obstructive sleep apnea, apolipoprotein E e4, and mild cognitive impairment. Sleep Med 2008 0.76
70 Myoclonus in Lewy body disorders. Adv Neurol 2002 0.76
71 APOE varepsilon2 and presymptomatic stage Alzheimer disease: how much is not enough? Neurology 2010 0.75
72 Correlates of quitting the Paced Auditory Serial Addition Test in cognitively normal older adults participating in a study of normal cognitive aging. J Clin Exp Neuropsychol 2011 0.75
73 Pituitary adenylate cyclase-activating polypeptide is reduced in Alzheimer disease. Neurology 2014 0.75
74 Compensation and finance in neurology. Ann Neurol 2008 0.75
75 Steroid-responsive encephalopathy subsequently associated with Alzheimer's disease pathology: a case series. Neurocase 2011 0.75
76 Lorazepam Challenge for Individuals at Varying Genetic Risk for Alzheimer Disease. Alzheimer Dis Assoc Disord 2017 0.75
77 January 16 highlight and commentary: subspecialization within somatosensory cortex. Neurology 2007 0.75
78 Giant cell arteritis. Curr Pain Headache Rep 2006 0.75
79 The (Mis)diagnosis of Creutzfeldt-Jakob Disease. Arch Neurol 2012 0.75